• Ian A Cook, Andrew C Wilson, Juliana Corlier, and Andrew F Leuchter.
• Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
• Neuromodulation. 2019 Dec 1; 22 (8): 894-897.

BackgroundSynchronized transcranial magnetic stimulation (sTMS) imparts low-amplitude magnetic stimulation matched to each patient's individual alpha frequency. It may act through entrainment of brain oscillations.ObjectivesTo explore sTMS effects on neurophysiology with electroencephalography (EEG) in adults with major depressive disorder.MethodsAs an ancillary study to a clinical trial of sTMS, EEGs were recorded at baseline and at one and six weeks of treatment. Associations between EEG measures and clinical symptoms were examined.ResultsAbsolute and relative power measures did not differ significantly between active and sham groups and did not change significantly over time. Changes occurring over six weeks in alpha current source density at anterior and central midline voxels were significantly correlated with changes in symptoms in subjects treated with active but not sham sTMS.ConclusionNeurophysiologic measures suggest that active but not sham sTMS engages brain targets, and that target engagement is related to treatment outcome.© 2019 International Neuromodulation Society.

23 keywords...

hide…